Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06972576RecruitingPhase 1
EphA2-targeted CAR-DC and CAR-T cell therapy for advanced lung cancer
This trial tests a new combination therapy using your own immune cells (CAR-T and CAR-DC) that are specially trained to attack a protein called EphA2 found on your lung cancer cells. It is for people with advanced non-small cell lung cancer whose cancer has continued to grow after other treatments.
Hangzhou, ZhejiangAges 18–70 - NCT06972602RecruitingEarly Phase 1
High-dose topotecan for retinoblastoma with vitreous seeds
This trial tests a high dose of a chemotherapy drug called topotecan given directly into the eye (intravitreal injection) for children with retinoblastoma that has come back or not responded to treatment and has seeds floating in the vitreous. The goal is to save the eye when removal is the only other option.
Shanghai, ChinaAges 1–12 - NCT06972901Recruiting
Preventing Crohn's recurrence after surgery using stool tests
This trial tests if checking a stool marker (fecal calprotectin) early after surgery can guide treatment with ustekinumab to prevent Crohn's disease from coming back. It's for people who had certain bowel surgery and have at least one risk factor for recurrence.
AmiensAges 18 years+ - NCT06973278Recruiting
SMILE vs SMILE Xtra for high myopia
This study compares two types of laser eye surgery (SMILE and SMILE Xtra) to see which works better for people with high myopia. It aims to help you understand which option might give you the best vision correction.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT06973356Recruiting
CAR-T therapy for severe, hard-to-treat ITP
This trial tests a new type of immunotherapy called CAR-T cells that target two proteins (CD19 and BCMA) on immune cells. It is for adults with severe ITP that has not improved with other treatments. The goal is to reset the immune system to stop attacking platelets.
Changsha, HunanAges 18 years+ - NCT06974305Recruiting
Brain imaging study for epilepsy
This study uses PET, MRI, and EEG scans to learn more about epilepsy. It may help researchers understand how the brain works in people with epilepsy and in healthy volunteers.
Charlestown, MassachusettsAges 18 years+ - NCT06974695Recruiting
Study on bile duct stone treatment success
This trial looks at why some bile duct stones don't clear after a special procedure using a tiny camera (cholangioscopy) to break them up. The goal is to help doctors predict who will have better results.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT06974994Recruiting
Antibiotic Use in Newborns and Gut Bacteria Health Study
This study explores how antibiotics given during delivery affect a baby's gut bacteria and long-term health. If you are pregnant or just gave birth and received antibiotics during labor, you and your newborn may be able to join.
Turku, Valitse Maakunta.Ages 2 hours+ - NCT06975384Recruiting
Sleep and lung cancer treatment outcome study
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
Changsha, HunanAges 18 years+ - NCT06976424RecruitingPhase 4
Face cream with or without laser for excess facial hair in women
This study tests whether combining a face cream with a laser treatment works better than the cream alone for reducing unwanted facial hair in women. It aims to find a more effective treatment for hirsutism (excess hair growth).
Peshawar, KpkAges 18–45 - NCT06977321Recruiting
Taping vs mud therapy for carpal tunnel syndrome
This study tests whether taping therapy (kinesiotaping) or a mud pack treatment (peloidotherapy) can help reduce pain and improve function for people with mild to moderate carpal tunnel syndrome. It may be an option if you want non-surgical, drug-free relief.
KonyaAges 1.5 years–5.4 years - NCT06977893RecruitingPhase 3
Chemo and immunotherapy for HR+ breast cancer before surgery
This trial tests whether adding the immunotherapy drug toripalimab to chemotherapy before surgery helps women with a certain type of breast cancer (HR+, HER2-). It aims to see if this combination works better than chemotherapy alone.
HangzhouAges 18–75 - NCT06978205Recruiting
Balloon dilation for urine retention after spinal cord injury
This trial tests if a balloon dilation procedure in the urethra can help people with spinal cord injury empty their bladder naturally. It looks at whether the treatment reduces the need for catheters.
Jinan, ShandongAges 18–80 - NCT06978439RecruitingPhase 4
Blood thinner dosing for children with Kawasaki aneurysm
This study tests the best dose of a blood thinner called rivaroxaban for children with a giant coronary artery aneurysm after Kawasaki disease. The goal is to prevent dangerous blood clots.
Shanghai, Shanghai MunicipalityAges 1 month–18 years - NCT06978933RecruitingPhase 2
Testing two new drugs for FGF19-positive liver cancer
This trial tests two new targeted drugs (ABSK-011 and ABSK043) for people with advanced liver cancer whose tumors have high levels of the FGF19 protein and who have already tried at least one other treatment.
ShanghaiAges 18 years+ - NCT06978985Recruiting
Adult SMA research and clinical hub study
This study creates a registry and clinical hub for adults with 5q spinal muscular atrophy (SMA). It aims to track health outcomes and improve care for people living with SMA.
BirminghamAges 16 years+ - NCT06979271Recruiting
Testing a new drug combo for tough rheumatoid arthritis
This trial tests whether combining Telitacicept and Tofacitinib can help people with rheumatoid arthritis that hasn't improved with at least two other advanced treatments. The goal is to see if these drugs work better together for hard-to-treat cases.
Hangzhou, ZhejiangAges 18–85 - NCT06979440Recruiting
Berberine for diabetes with depression
This trial tests if berberine, a natural compound, can improve both blood sugar and mood in people who have type 2 diabetes and major depression. It aims to understand how berberine works at a molecular level.
Nantong, JiangsuAges 18–65 - NCT06979466Recruiting
Electrical device for chronic stroke recovery
This trial tests a device that uses electrical stimulation to help people who had a stroke several months to years ago improve arm and hand movement. You would use the device while sitting and do physical exercises with help from a caregiver.
White Plains, New YorkAges 18–80 - NCT06979700Recruiting
Early wake-up predictors after cardiac arrest
This study looks at patients who had a cardiac arrest outside the hospital and are still unconscious after their heartbeat returns. The goal is to find early signs that predict when someone will wake up.
Aarhus NAges 18 years+ - NCT06979869Recruiting
Esophageal cancer gene test for treatment response
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
Wuwei, GansuAges 18–75 - NCT06979908RecruitingPhase 2
A study of fruquintinib plus immunotherapy for advanced colorectal cancer
This trial tests a combination of three drugs (fruquintinib, a PD-1 inhibitor, and chidamide) for people with a specific type of advanced colorectal cancer that has not responded to at least two prior treatments. The goal is to see if this new combination can shrink tumors or slow the cancer's growth.
Changchun, JilinAges 18–75 - NCT06980259Recruiting
Comparing two types of radiation for soft tissue sarcoma
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
Jinan, ShandongAges 18–70 - NCT06980597RecruitingPhase 1
Testing OL-108 for active autoimmune diseases
This trial tests an investigational drug called OL-108 for people with certain autoimmune diseases (lupus, myositis, scleroderma, or vasculitis) that have come back or not responded to standard treatments. The goal is to see if it's safe and if it can help control the disease.
BeijingAges 18–65
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.